Abstract
Abstract
Aim
This study was designed to evaluate the frequency of developing second and subsequent primary cancers among cancer survivors.
Methods
We have retrospectively analyzed 121 multiple primary cancer patients treated at Bhagwan Mahavir Cancer Hospital and Research Centre, Jaipur, Rajasthan, India from the last 20 years. The survival analysis was performed by Kaplan-Meier methodology.
Results
The prevalence of multiple primary malignant tumors (MPMTs) was 1.51% (121/8000), with a male to female ratio of 1:1.42. In males most of the reported MPMTs were synchronous and most common first primary cancer cases were head & neck and lung whereas, in females most of the reported MPMTs were metachronous and most common first primary cancer cases were breast and gynaecological malignancies. Family history was reported in 15 cases. Maximum 33.05% patients received combined treatment of chemotherapy, radiotherapy and 91.73% (111/121) of patients with MPMTs were effectively followed up, 35 (28.92%) patients died and 5-year survival rate of the remaining 86 patients was 68.46%.
Conclusions
In the present observational study the most frequent sites of MPMTs in men were head & neck and lung whereas, in women breast and gynaecological sites were common. Therefore, careful monitoring and follow up are required for these patients.
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. AIRTUM Working Group. Italian cancer figures, report 2013: Multiple tumours. Epidemiol Prev. 2013;37(4–5 Suppl 1):1–152 PMID: 24259384.
2. Angurana SL, Kapoor R, Kumar P, Khosla D, Kumar N, Sharma SC, et al. Quadruple malignancy in a single patient: a case report and comprehensive review of literature. J Cancer Res Ther. 2010;6:230–2. https://doi.org/10.4103/0973-1482.65237.
3. Bagri PK, Singh D, Singhal MK, Singh G, Mathur G, Jakhar SL, Beniwal S, Sharma N, Kumar HS, Sharma A, Bardia MR. Double primary malignancies: a clinical & pathological analysis report from a regional cancer institute in India. Iran J Cancer Prev. 2014;7(2):66–72 PMID: 25250152; PMCID: PMC4142942.
4. Băltătescu GI, Așchie M, Sârbu V. Synchronous ovarian dysgerminoma and breast carcinoma in a patient with positive immunostain of BRCA1. Chirurgia (Bucur). 2013;108(2):259–63 PMID: 23618579.
5. Bishen KA, Singh A. A case of dual malignancy: presenting the necessity for extensive sampling for pathologic examination. J Oral MaxillofacPathol. 2011;15:306–10. https://doi.org/10.4103/0973-029X.86698.